Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azilsartan Medoxomil/Chlorthalidone vs Olmesartan/HCTZ in Hypertension
NCT01033071Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2010
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of azilsartan medoxomil in essential hypertension, sponsored by Takeda. Started Jan 2010; status: completed.
02
Drugs
azilsartan medoxomil
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT01033071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01033071.